| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | IRIX Iridex Corporation | Dizon Romeo R57 | Chief Financial Officer | Buy | 1,110 | $1.26 | $1,398.60 | +0.9% | - | - | |
| Mar 6, 2026 | CERS Cerus Corporation | Greenman William Mariner72 | President And CEO | Sell | 78,187 | $2.01 | $156,804.03 | -1.4% | - | - | |
| Mar 6, 2026 | CERS Cerus Corporation | Green Kevin Dennis73 | Chief Financial Officer | Sell | 83,021 | $2.04 | $169,646.44 | -3.4% | - | - | |
| Mar 6, 2026 | CERS Cerus Corporation | Jayaraman Vivek K67 | Chief Operating Officer | Sell | 34,094 | $2.01 | $68,375.52 | -1.8% | - | - | |
| Mar 6, 2026 | CERS Cerus Corporation | Jensen Chrystal72 | Chief Legal Officer | Sell | 30,845 | $2.01 | $61,859.65 | -2.8% | - | - | |
| Mar 5, 2026 | STE Steris Plc | Feldmann Cynthia L52 | Director | Sell | 3,098 | $237.21 | $734,876.58 | -81.5% | -10.8% | - | |
| Mar 5, 2026 | ISRG Intuitive Surgical, Inc. | Brosius Mark52 | SVP &Chief Mfg And Supply Cha | Sell | 3,658 | $496.19 | $1,815,061.50 | -22.8% | -14.5% | - | |
| Mar 4, 2026 | RSMDF Resmed Inc. | Farrell Peter C54 | Director | Sell | 2,000 | $260.22 | $520,440.00 | -3.1% | - | - | |
| Mar 4, 2026 | STIM Neuronetics, Inc. | MacAn William Andrew66 | EVP, CLO And Cs | Sell | 609 | $1.34 | $816.06 | - | +15.8% | - | |
| Mar 4, 2026 | NVCR Novocure Limited | Leupin Nicolas | Former Chief Medical Officer | Sell | 1,100 | $13.31 | $14,635.94 | -1.1% | +27.0% | - | |
| Mar 4, 2026 | TMDX Transmedics Group, Inc. | Weill David60 | Director | Sell | 3,571 | $146.82 | $524,294.22 | -22.7% | -54.6% | - | |
| Mar 4, 2026 | TMDX Transmedics Group, Inc. | Lovell Stephanie | Director | Sell | 1,193 | $149.62 | $178,496.66 | -29.4% | -54.6% | - | |
| Mar 4, 2026 | TMDX Transmedics Group, Inc. | Hernandez Gerardo | Chief Financial Officer | Sell | 7,611 | $146.81 | $1,117,381.56 | -14.7% | -54.6% | - | |
| Mar 3, 2026 | CBLL Ceribell, Inc. | Foehr David | Senior VP, Finance And Pao | Sell | 4,560 | $17.80 | $81,168.00 | -11.5% | +5.2% | - | |
| Mar 3, 2026 | CBLL Ceribell, Inc. | Robertson Rebecca B81 | Director | Sell | 827 | $17.80 | $14,720.60 | -4.2% | +5.2% | - | |
| Mar 3, 2026 | CBLL Ceribell, Inc. | Chao Xingjuan57 | President And CEO | Sell | 39,000 | $17.45 | $680,564.46 | -1.8% | +5.2% | - | |
| Mar 2, 2026 | IRTC Irhythm Holdings, Inc. | Blackford Quentin S.59 | President And CEO | Sell | 13,813 | $128.44 | $1,774,173.93 | -2.2% | -11.3% | - | |
| Mar 2, 2026 | IRTC Irhythm Holdings, Inc. | Wilson Daniel G.62 | Chief Financial Officer | Sell | 3,395 | $128.45 | $436,076.41 | -2.2% | -11.3% | - | |
| Mar 2, 2026 | SINT Sintx Technologies, Inc. | Lyons Christopher Michael | Director | Buy | 8,292 | $2.91 | $24,092.28 | +1,094% | -20.6% | - | |
| Mar 1, 2026 | NMTC Neuroone Medical Technologies Corporation | Wambeke David J.63 | Chief Business Officer | Buy | 1,000,000 | $0.67 | $670,400.00 | New | +427.4% | - | |
| Feb 25, 2026 | PODD Insulet Corporation | Minogue Michael R | Director | Buy | 2,030 | $246.23 | $499,846.90 | +13.1% | -38.0% | - | |
| Feb 24, 2026 | SRTS Sensus Healthcare, Inc. | Sachetta Eric | Director | Buy | 2,000 | $3.81 | $7,620.00 | +1.4% | -16.7% | - | |
| Feb 23, 2026 | SINT Sintx Technologies, Inc. | Moyes Jay M53 | Director | Buy | 1,000 | $2.91 | $2,910.00 | +33.3% | -17.9% | - | |
| Feb 20, 2026 | PODD Insulet Corporation | McEvoy Ashley | President And CEO | Buy | 4,300 | $239.35 | $1,029,205.00 | +44.7% | -35.1% | - | |
| Feb 19, 2026 | CBLL Ceribell, Inc. | Parvizi Josef60 | Director | Sell | 16,714 | $20.27 | $338,792.78 | -2.3% | -10.8% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.